Provided by Tiger Trade Technology Pte. Ltd.

CINGULATE INC.

4.76
+0.01000.21%
Post-market: 4.760.00000.00%19:34 EDT
Volume:52.62K
Turnover:252.32K
Market Cap:69.22M
PE:-1.34
High:4.90
Open:4.79
Low:4.71
Close:4.75
52wk High:11.89
52wk Low:3.16
Shares:14.54M
Float Shares:14.11M
Volume Ratio:0.52
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5600
EPS(LYR):-4.4408
ROE:-198.74%
ROA:-66.94%
PB:2.95
PE(LYR):-1.07

Loading ...

Cingulate Inc Added to Broad Russell 3000E Index

TIPRANKS
·
Jul 02

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

GlobeNewswire
·
Jul 02

Cingulate issues patent by USPTO for CTx-1301

TIPRANKS
·
Jun 16

Cingulate wins first US patent for ADHD drug CTx-1301, exclusivity to December 2042

Reuters
·
Jun 16

Cingulate director Jeff Hargroves acquires 97,276 common shares for $490,271.04

Reuters
·
Jun 09

Cingulate files Form 3 initial beneficial ownership statement for director Jeff Hargroves

Reuters
·
Jun 09

Cingulate Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Jun 08

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Reuters
·
Jun 02

Cingulate Faces FDA Delay But Maintains ADHD Drug Plans

TIPRANKS
·
Jun 02

FDA declines to approve Cingulate's ADHD treatment over manufacturing issues

Reuters
·
Jun 02

BRIEF-Cingulate Receives Complete Response Letter From FDA For CTx-1301

Reuters
·
Jun 02

Cingulate gets FDA complete response letter for ADHD drug CTx-1301 on CMC issues

Reuters
·
Jun 02

Cingulate - Has Nearly $30 Mln in Cash Reserves to Fund Operations Into 2027

THOMSON REUTERS
·
Jun 02

Cingulate Receives Complete Response Letter From FDA for Ctx-1301

THOMSON REUTERS
·
Jun 02

Cingulate - FDA Identifies Cmc Requests, No Current Safety or Efficacy Concerns for Ctx-1301

THOMSON REUTERS
·
Jun 02

Cingulate - Expects Prompt Submission of Requested Information to FDA

THOMSON REUTERS
·
Jun 02

Cingulate Receives Complete Response Letter from FDA for CTx-1301

GlobeNewswire
·
Jun 02

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Jun 02

Cingulate Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
May 26

Analysts Are Bullish on These Healthcare Stocks: Roche Holding AG (RHHVF), Cingulate Inc (CING)

TIPRANKS
·
May 26